At a glance
ClinicalIndex Comparison Record- ✓Participated in acute treatment for binge-eating disorder and obesity
- ✓Did not have a positive response to acute treatment
- ✓Available for 20 months of treatment and follow-up
- ✓Able to travel to study location (New Haven, CT) for weekly visits
- ✕Currently taking antidepressant medications
- ✕Currently taking opioid pain medications or drugs
- ✕Currently taking medications that influence eating or weight
- ✕History of seizures
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity
In Brief
A Phase 3 clinical trial evaluating Cognitive-Behavioral Therapy (CBT) and NB Medication (on-going from acute treatment) for Binge-Eating Disorder and Obesity. Completed, enrolled 31 participants across 1 site.
Detailed Summary
This study will test the effectiveness of cognitive-behavioral therapy as a specialist treatment for binge eating disorder (BED) in patients with obesity. This is a controlled test of whether, amongst non-responders to acute treatments, cognitive-behavioral therapy augments on-going blinded pharmacotherapy (either naltrexone/bupropion or placebo), compared with no additional behavioral treatment .
Study Details
Timeline
Interventions
CBT specialist treatment
Naltrexone/bupropion combination (on-going blinded pharmacotherapy from acute treatment consisting of either naltrexone/bupropion or placebo)